Positron Corporation today announced that the Company
has recently received approval from Health Canada to use Positron's mPower PET
scanner in oncology and cardiology clinical trials in Canada. Positron is developing
a broad range of applications and upgrades to its mPower line and will be rapidly
expanding the approved uses of its mPower product in Canada.
The Houston Chronicle